SRX Global Inc. (SRXH)
CIK 1471727 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 590.3M shares as of May 13, 2026 (10-Q). Share count fell from 60.2M to 60,200 between Jul 6, 2012 and Dec 13, 2012, a pattern consistent with a reverse split (roughly 1-for-1000); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Warrant | 21.3M | not tagged | — | — |
| Pre Funded Warrants | 2.8M | not tagged | — | — |
| Pre Merger Representative Warrants | 83,350 | $3.75 | — | — |
| Pre Merger Pre Funded Warrants | 49,000 | $3 | — | — |
| Series B Warrants | not tagged | $0.3182 | — | — |
Tranches exactly as the company dimensioned them in its 10-Q filed May 14, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 132.2M underlying shares, as reported Sep 30, 2024 (8-K/A).
Reported exercise price: $0.6274 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $0 as of Dec 31, 2021.
Rough fully diluted estimate: 722.5M = 590.3M O/S + 132.2M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
| Note | Principal | Carrying | Conv. price | Rate | If converted |
|---|---|---|---|---|---|
| July Twenty Twenty Five Convertible Notes | $7.7M | $0 | $0.6274 | 8% | ~12.2M sh |
| Convertible Note Receivable | $1.5M | — | not tagged | 10% | — |
If every note above converted at its tagged price: ~12.2M new shares on 590.3M currently outstanding. An estimate from principal ÷ conversion price, with inputs carrying different as-of dates; make-whole adjustments, capped calls and partial repurchases are not modeled.
Notes exactly as the company dimensioned them in its 10-Q filed May 14, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 590.3M | May 13, 2026 |
| + Warrant (if exercised) | 21.3M | Mar 31, 2026 |
| + Pre Funded Warrants (if exercised) | 2.8M | Apr 24, 2025 |
| + Pre Merger Representative Warrants (if exercised) | 83,350 | Mar 31, 2026 |
| + Pre Merger Pre Funded Warrants (if exercised) | 49,000 | Mar 31, 2026 |
| + July Twenty Twenty Five Convertible Notes (if fully converted) | 12.2M | Jul 7, 2025 |
| Fully diluted estimate | 626.7M | +6.2% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $56.5Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 3 executed · 4 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full SRXH workspace